- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 9, 2025 | 58.38M sh |
| Long Term Debt | Q1 2024 · Mar 31, 2025 | $1.95M |
| Long Term Debt | Q1 2024 · Dec 31, 2024 | $36.71M |
| Short Term Debt | Q1 2024 · Mar 31, 2025 | $64.92M |
| Short Term Debt | Q1 2024 · Dec 31, 2024 | $43.88M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2025 | $1.47M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2024 | $678.68K |
| Current Liabilities | Q1 2024 · Mar 31, 2025 | $117.44M |
| Current Liabilities | Q1 2024 · Dec 31, 2024 | $97.25M |
| Total Liabilities | Q1 2024 · Mar 31, 2025 | $120.51M |
| Total Liabilities | Q1 2024 · Dec 31, 2024 | $134.77M |
| Current Assets | Q1 2024 · Mar 31, 2025 | $72.68M |
| Current Assets | Q1 2024 · Dec 31, 2024 | $88.02M |
| Total Assets | Q1 2024 · Mar 31, 2025 | $106.47M |
| Total Assets | Q1 2024 · Dec 31, 2024 | $122.75M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2024 | 25.42M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $14.62K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2024 | $11.23M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | $16.81M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | −$39.35M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2024 | −$0.19 |
| Eps Basic restated | Q1 2024 · Mar 31, 2024 | −$0.19 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $10.34M |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$4.87M |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$1.14M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $10.47M |
| Revenue | Q1 2024 · Mar 31, 2024 | $100.62M |